Company News

Northern Industrial appoints Lynsey Doran Congenica appoints CFO Tri-Seal appoints VP and General Manager for North America CellResearch Corporation makes new leadership appointments Almac Group appoints Site Head for Charnwood Campus Sobi appoints Head of Technical Operations New wave of cell biology experts take centre stage Ashfield appoints new Managing Director ERT appoints industry veteran to advance eCOA strategy Almac Group appoints Jonothan Cooil Lytix Biopharma appoints Gjest Breistein as CFO Medical Ethics appoints British Army surgeon to advisory board Hikma Pharmaceuticals appoints VP of Sales and Marketing A1M Pharma appoints Chief Medical Officer Publicis Health Solutions promotes Amy Jamison to VP PureTech’s Karuna appoints CEO Christopher Klumph joins Charkit Chemical Company Vacancy at Sterling Pharmaceuticals: Maintenance Engineer Vacancy at Sterling Pharmaceuticals: Analytical Chemist (R and D) Sphere Fluidics appoints scientific advisor Concept Life Sciences appoints East Coast Business Development Director Zelluna Immunotherapy appoints Chief Scientific Officer CNH Industrial appoints CEO Quanticate names Senior Director of Pharmacovigilance

Trending Articles

  1. Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Announcement follows several years of stellar growth and points to a sharper focus on expanding commercial NCE opportunities
  2. FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, announced the appointment of Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026
  3. Kindeva appoints Mike Cowhig as Chief Legal Officer The appointment will drive legal strategy, enterprise risk management and corporate governance across the organisation
  4. Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back The appointment of Susanne Back as Head of In Vivo Pharmacology will further strengthen its bioscience leadership and reinforcing its commitment to delivering high-quality, integrated drug discovery solutions for customers worldwide
  5. Germfree appoints Chief Executive Officer Carol Houts brings 30 years of healthcare and life sciences leadership to Germfree’s next phase of growth and execution

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all